|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|||||||||||||||||||||
|
|
|
![]() |
|
||||||||||||||||||||
![]() |
|
||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
![]() |
|
||||||||||||||||
|
|
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
Workplace exposure to asbestos is a serious occupational health problem in the United States. Asbestos related diseases include asbestosis, lung cancer, malignant mesothelioma, nonmalignant pleural disease, cancer of the larynx or cancer of the gastrointestinal tract
(More About Asbestos) (Return to top)
Product Liability Baxter Dialyzers
Baxter dialyzers were voluntarily recalled (Baxter recall notice) after reports of deaths associated with its product in kidney dialysis patients in Spain, Croatia, Italy, Germany, Taiwan, Colombia and the U.S. The U.S. deaths occurred at dialysis facilities in Austin, Texas, and Kearney, Neb. Most of the dialysis patients who died experienced shortness of breath, chest tightness, cardiac arrest or stroke symptoms within hours of being dialyzed.
(More About Baxter Dialyzers) (Return to top)
Product Liability Baycol (cerivastatin)
Bayer Pharmaceutical Division (website) has announced plans to withdraw Baycol, also known as cerivastatin. Pharmacies will be instructed to return the product to the manufacturer for a refund. Baycol, which was initially approved in the U.S. in 1997, is a member of a class of cholesterol lowering drugs that are commonly referred to as "statins." Cases of fatal rhabdomyolysis in association with the use of Baycol have been reported significantly more frequently than for other approved statins. Rhabdomyolysis is a condition that results in muscle cell breakdown and release of the contents of muscle cells into the bloodstream.
(More About Baycol) (Return to top)
Product Liability Celebrex (celocoxib capsules)
Celebrex (website), manufactured by Pfizer (website), may cause stomach ulcers that bleed. The chance of this serious problem increases the longer you take Celebrex and with higher doses of Celebrex. Stomach bleeding can sometimes happen suddenly in patients taking Celebrex.
(More About Celebrex) (Return to top)
Ephedra, commonly known as Ma Huang, is an amphetamine -like compound with potentially powerful stimulant effects on the nervous system and heart. The Food and Drug Administration (FDA - website) has received and investigated more than 800 reports of adverse events associated with the use of ephedrine alkaloid-containing products since 1994. These events ranged from episodes of high blood pressure, heart rate irregularities, insomnia, nervousness, tremors and headaches, to seizures, heart attacks, strokes and death.
(More About Ephedra) (Return to top)
At the request of the Food and Drug Administration, Wyeth-Ayerst Laboratories and Interneuron Pharmaceuticals, which manufactured and marketed fenfluramine under the brand name Pondimin and dexfenfluramine under the brand name Redux, voluntarily withdrew these products from the market. Anyone who has taken fenfluramine or dexfenfluramine for any period of time, should see their doctor for a medical history and physical examination to determine whether there are signs or symptoms of heart or lung disease.
(More About Fen-Phen) (Return to top)
Kava (Piper methysticum) is a plant indigenous to the islands in the South Pacific where it is commonly used to prepare a traditional beverage. Supplements containing the herbal ingredient kava are promoted for relaxation, sleeplessness, menopausal symptoms and other uses. Possible liver-related risks associated with the use of kava have prompted regulatory agencies in other countries, including those in Germany, Switzerland, France, Canada, and the United Kingdom, to take action ranging from warning consumers about the potential risks of kava use to removing kava-containing products from the marketplace
(More About Kava) (Return to top)
Product Liability Meridia (sibutramine hydrochloride monohydrate) Abbott Laboratories (website)
Although Meridia has been implicated in the deaths of 29 users in 3 years from apparent cardiac complications, Abbott Laboratories has not voluntarily withdrawn Meridia from the market. Abbott Labs refutes death claims related to Meridia.
(More About Meridia) (Return to top)
Product Liability PPA (phenylpropanolamine)
The Food and Drug Administration (FDA) removed phenylpropanolamine (PPA) from all drug products and has requested that all drug companies discontinue marketing products containing PPA. Phenylpropanolamine is an ingredient used in many over-the-counter and prescription cough and cold medications, and in weight loss products.
(More About PPA) (Return to top)
Product Liability Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) Wyeth (website)
Prempro contains two kinds of hormones: estrogens and a progestin. Long-term risks of Prempro in postmenopausal women include increased risks of breast cancer and thromboembolic disease associated with estrogen and combination estrogen/progestin therapy, as well as increased risk of cardiovascular disease, including myocardial infarction and stroke, in healthy women.
(More About Prempro) (Return to top)
Janssen Pharmaceutica (website), the manufacturer of the prescription drug Propulsid (cisapride), announced that it was voluntarily withdrawing the drug from the U.S. market. Propulsid is a prescription drug treatment for severe nighttime heartburn experienced by patients with gastroesophageal reflux disease. Propulsid has been associated with a significant number of reports of heart rhythm abnormalities and several deaths.
(More About Propulsid) (Return to top)
Product Liability Rezulin (troglitazone)
The FDA asked the manufacturer, Pfizer (Website), of Rezulin (troglitazone), a drug used to treat type 2 diabetes mellitus, to remove the product from the market. The drug's manufacturer, Parke-Davis/Warner-Lambert, has agreed to remove it. The FDA took this action after its review of recent safety data on Rezulin and two similar drugs, rosiglitazone (Avandia) and pioglitazone (Actos), showed that Rezulin is more toxic to the liver than the other two drugs.
(More About Rezulin) (Return to top)
Cases of life-threatening hepatic failure have been reported in patients treated with Serzone (nefazodone hydrochloride) (website), manufactured by Bristol-Myers Squibb Company (website). The reported death rate in the United States is about 1 case of liver failure resulting in death or transplant per 250,000 300,000 patient-years of SERZONE treatment. This represents a rate of about 3-4 times the estimated background rate of liver failure.
(More About Serzone) (Return to top)
Product Liability Sulzer Hip and Knee Products
The Sulzer Settlement Trust issued payments totaling over $285,000,000 to approximately 5,500 claimants who filed Claims arising from the implantation of certain hip and knee replacement joints manufactured by United States subsidiaries of Swiss medical device manufacturer, Sulzer (now Centerpulse) (website).
(More About Sulzer) (Return to top)
Bleeding and other serious problems from stomach ulcers are known complications in people treated with NSAIDs. Similar problems have arisen in people treated with Vioxx (rofecoxib), manufactured by Merck & Co., Inc. (website), although very rarely. The likelihood of stomach problems increases the longer you take drugs like Vioxx. However, even short-term treatment is not without risk. Symptoms include gnawing or burning stomach pain, black or tarry stools or vomiting. If symptoms occur, stop taking Vioxx and call your health care provider.
(More About Vioxx) (Return to top)
Your personal injury case is subject to the statute of limitations. If you don't act now you may lose your right to compensation for the personal injury you have sustained. Contact Houston personal injury lawyer Christian Hill at the law firm of Christian Hill and Associates as soon as possible.
[areas of practice] [staff] [experience] [satisfied clients]
[recent cases][submit your case] [contact us] [home]
Copyright © 2008, Christian Hill & Associates
Search Engine Marketing
Disclaimer